A Welcome Oral for Rheumatoid Arthritis

Dr. Jonathan Kay discusses a new first-in-class agent for rheumatoid arthritis recently recommended for approval by an FDA advisory panel.

Source: Medscape Rheumatology Podcast - July 6, 2012 Category: Rheumatology Authors: Medscape Source Type: podcasts